← Back to catalogue

Architect

FDA UDI

Class II (US FDA UDI)

by Abbott Ireland Diagnostics

Identity

Trade Name
ARCHITECT FDA UDI
Generic Name
Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent FDA UDI
Device Name
ARCHITECT Sirolimus Whole Blood Precipitation Reagent FDA UDI
Model / Reference
1L76-55 FDA UDI
Description
ARCHITECT Sirolimus Whole Blood Precipitation Reagent FDA UDI

Identifiers

Catalog Number
01L7655 FDA UDI
Primary DI / UDI-DI
00380740001353 FDA UDI
FDA Product Code
JIT FDA UDI
NRP FDA UDI
GMDN Term
Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1150 FDA UDI
862.3840 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

Yes

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent

Architect by Abbott Ireland Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Ireland Diagnostics

Sources (1)

  • FDA UDI 69276a56-b9d6-4817-98b1-e203ef5516cd 36 fields · synced May 30, 2026